First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 6.4% of the 1,940,000 shares held after it.
No other insider bought within 30 days.
Insider activity: CEO, CFO and Director Levy Ron bought about $25.0K of CRCW on Feb 9, 2023, the largest insider purchase at the company on our record.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$17.0K
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM CRCW
FY Dec 2025
$18.5K
FY Dec 2024
$44.8K
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
$434.6K
Jun 2026
$1.5K
Mar 2026
$4.0K
Dec 2025
$4.3K
Sep 2025
$7.1K
Jun 2025
$4.2K
Mar 2025
$2.9K
Dec 2024
$8.9K
Sep 2024
$10.3K
At each fiscal year end
Single quarter
Net margin, TTM
n/a
revenue under $1M, the ratio says nothing
Net margin, TTM CRCW
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Free cash flow, TTM
-$1.4M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM CRCW
FY Dec 2025
-$1.5M
FY Dec 2024
-$863.5K
FY Dec 2023
-$1.7M
FY Dec 2022
-$2.0M
FY Dec 2021
-$194.9K
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Debt to equity
n/a
equity is zero or negative, the ratio has no meaning
Debt to equity CRCW
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
-11.07x
TTM operating cash flow over long-term debt only, 2023-12-31 (30 months older than the period end)
Cash flow to debt CRCW
FY Dec 2025
-11.29x
FY Dec 2024
-6.51x
FY Dec 2023
-13.14x
FY Dec 2022
-15.44x
FY Dec 2021
-1.22x
Jun 2026
-11.07x
Mar 2026
-9.80x
Dec 2025
-11.29x
Sep 2025
-11.19x
Jun 2025
-4.06x
Mar 2025
-4.97x
Dec 2024
-6.51x
Sep 2024
-10.85x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
n/a
average equity is zero or negative
Return on equity CRCW
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
-8,837%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets CRCW
FY Dec 2025
-1,779%
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
-367.4%
FY Dec 2021
n/a
Jun 2026
-8,837%
Mar 2026
-7,502%
Dec 2025
-1,779%
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
tax provision or pre-tax income not filed for the four quarters
Return on invested capital CRCW
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
capital employed is zero or negative
Return on capital employed CRCW
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
fewer than four consecutive quarters of diluted EPS
P/E, trailing CRCW
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
0.05x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$4.2M
market value at close 2026-10-27 on 2026-08-18 shares, plus long-term debt only, 2023-12-31 (30 months older than the period end), minus cash 2026-06-30
Enterprise value CRCW
FY Dec 2025
$14.4M
FY Dec 2024
$2.7M
FY Dec 2023
$671.6K
FY Dec 2022
$5.3M
FY Dec 2021
$80.1M
Jun 2026
$5.6M
Mar 2026
$4.9M
Dec 2025
$14.4M
Sep 2025
$30.9M
Jun 2025
$3.6M
Mar 2025
$2.7M
Dec 2024
$2.7M
Sep 2024
$2.1M
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
-35.1%
TTM free cash flow over market value at close 2026-10-27
FCF yield CRCW
FY Dec 2025
-10.2%
FY Dec 2024
-33.4%
FY Dec 2023
-273.1%
FY Dec 2022
-37.5%
FY Dec 2021
-0.2%
Jun 2026
-26.1%
Mar 2026
-26.7%
Dec 2025
-10.2%
Sep 2025
-4.6%
Jun 2025
-15.9%
Mar 2025
-26.0%
Dec 2024
-33.4%
Sep 2024
-70.9%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
fewer than four consecutive quarters of diluted EPS
PEG, trailing CRCW
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
Debt to equityequity is zero or negative, the ratio has no meaning
Cash flow to debt-11.07x · 9 pct, sector of 241
Growth
5
Inputs
Revenue growth, YoY-58.7% · 5 pct, sector of 480
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
5 not measured: Profitability, Insider conviction, Institutional and government, Risk and compliance, US patents
Profitability needs 2 of 4 inputs, 1 present: average equity is zero or negative; capital employed is zero or negative; tax provision or pre-tax income not filed for the four quarters
Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
Risk and compliance needs 1 of 4 inputs, 0 present: needs two 10-Ks with a Risk Factors section (not 20-F filers or stubs); no short interest or no free float on file; revenue under $50M or not filed, so a count cannot be scaled to size
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
2 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.